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Background: Obesity has been found to be associated with colon cancer. However, the mechanism of this 
relationship is unclear and thus a good animal model is required. Our previous research showed that 
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formation due to obesity-related cancer risk factors and different gene expression from DR mice. 
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Background: Obesity has been found to be associated with colon cancer. However, the mechanism of this 
relationship is unclear and thus a good animal model is required. Our previous research showed that some mice 
developed diet-induced obesity (DIO) whilst others were diet-resistant (DR) when fed a high-fat diet. 
Methods: In the present study, we have tested the effects of a high-fat diet on the formation of colon polyps 
induced by azoxymethane (AOM) in both DIO and DR mice. 
Results: We found that the DIO mice have developed 2.5 times of polyps compared to the DR mice (P<0.05) and 
3.4 times of polyps compared to the low fat fed mice (P<0.05). Although the DR mice tended to have more polyps 
than the low-fat diet fed mice, this was not statistically significant. The DIO mice could have an increased polyp 
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Introduction
Obesity is increasing worldwide, and represents a high 
proportion of the population in developed countries. 
It not only causes diabetes, heart disease and hyper-
cholesterolemia,  but also is  l inked to cancer (1) . 
Epidemiological studies have shown that obesity increases 
the incidence of several cancers including endometrial, 
esophageal, breast, liver, renal and colon cancer (1). Obesity 
also results in poorer prognosis for colon cancer (2,3). 
However, the mechanisms of obesity-associated colon 
cancer are not fully understood. Further research could 
elucidate these mechanisms as well as provide effective 
prevention and treatment approaches. However, to do this 
we require good animal models.
At present, there are limited animal models available. 
The most commonly used animal models for obesity 
include ob/ob mice, db/db mice and Zucker rats; all of 
them have gene mutations (4,5). These models have 
been used to study the effect of obesity on colon cancer 
induced by azoxymethane (AOM) showing that obesity 
does increase the incidence of colon cancer (6,7). The db/
db mouse model has also been used in preventative studies 
using branch amino acids (5), green tea (8) and dietary 
flavonoids (9). A study using kk-A(y) obese mice showed 
that the number of polyps induced by AOM had a 22-
fold increase when compared to the controls (4). However, 
these animals either lack leptin or have a mutation that 
inactivates the leptin receptor Ob-Rbl, leading to the 
disruption of leptin-induced intracellular signalling (4). 
Leptin can promote colorectal cancer development by 
activating multiple signalling pathways such as MAPK and 
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PI3K/Akt (10). Therefore, it is desirable to use animals with 
intact leptin and the leptin receptor Ob-Rbl to investigate 
obesity-associated colorectal cancer.
Obese C57Bl/6 mice have been used to study obesity 
and colon cancer. One particular study showed that a 
high-fat diet can increase polyp formation induced by 
AOM in mice (11). However, another study using the 
same model reported that a high-fat diet for 15 weeks 
did not affect the growth of the xenograft tumour 
although body weight increased (12). This discrepancy 
may be caused by not distinguishing diet-induced obese 
(DIO) and diet-resistant (DR) mice. Previous studies 
have shown that mice or rats fed a high-fat diet may 
either develop obesity or resist to obesity development 
as they have about the same body weight as mice fed 
lab chow diet (13-16). The DR mice or rats have quite 
different blood profiles of cancer risk factors that 
mediate obesity-increased cancer such as blood levels 
of leptin and insulin (17,18). The gene expression in 
DIO and DR is also different (19,20). Using non-obese 
DR mice in the experiments could dilute the effect of 
obesity on carcinogenesis. In the present study, we aimed 
to investigate the effects of obesity on AOM-induced 
colon polyp formation using DIO mice in comparison 
with DR mice. We showed that DIO mice had a greater 
susceptibility to AOM-induced colon polyp formation 
than DR mice, although they were fed an identical high-
fat diet. This demonstrated that the DIO mice could be a 
good model for studying obesity-associated colon cancer.
Methods
Animals
The 6-week-old C57Bl/6 male mice were purchased 
from Animal Centre (Perth, Australia), and allowed 
1 week acclimatisation to laboratory conditions. Mice 
were housed three per plastic cage with wood chips as 
bedding in a barrier-sustained animal room at 24±2 ℃ 
and 55% humidity on a 12-hour light/dark cycle and fed 
either a high-fat diet (3.80 kcal/g, 40% of energy from 
fat) or a low-fat diet (2.59 kcal/g, 10% of energy from fat). 
Food and water were available ad libitum. The animals 
were observed daily for clinical signs including general 
activity, hair and mortality. Body weight was measured 
weekly. All experiments were performed according to the 
requirement of Animal Ethics Committee for University 
of Wollongong (AE09/02), Australia.
AOM treatment
Following 6 weeks of either a high or low-fat diet, the mice 
were divided into three groups including DIO, DR and LF. 
All mice were injected with AOM intraperitoneally at dose of 
10 mg/kg once a week for 6 weeks. The mice were then fed 
a high- or a low-fat diet for another 14 weeks before being 
sacrificed for the examination of colon polyp formation.
Examination of polyp formation
The entire colons of these mice were isolated and fixed in 
10% formalin. The formation of polyps in the colon was 
examined. The colons were stained with 0.2% methylene 
blue and polyps were counted under a light microscope.
Statistical analysis
Statistics were performed using one-way ANOVA (SPSS, 
Chicago, USA), where P<0.05 was considered as statistically 
significant.
Results
To study the effect of obesity on colon cancer, 6-week-old 
mice were fed a high-fat diet for a period of 6 weeks. Mice 
were then separated into three groups as per our previous 
studies (21). Those with the highest weight gains were 
designated as DIO mice and those with the lowest weight 
gains were grouped as DR mice. The mice with medium 
weight gains were not used for the following experiments. 
Statistical analyses showed that the DIO mice were 
significantly heavier (15%) than the DR and control mice. 
The DR mice had a similar body weight gain as the LF 
mice with no statistical difference. 
The number of colon polyp formed was counted in the 
three groups of mice (DIO, DR and LF). It was found that 
the DIO mice developed 2.5 times of polyps compared to 
the DR mice and 3.4 times of polyps compared to the low-
fat fed mice (Figure 1A). Large polyps were also observed in 
DIO mice with AOM treatment (Figure 1B). Histological 
examination showed the disarrangement of the colon 
epithelial cells (Figure 1C). 
Discussion
In the present study, we showed that the DIO mice have 
increased polyp formation after the injection of AOM 
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when compared to the DR mice and control mice fed a 
low-fat diet. This result suggests the DIO mice could be 
a suitable model for studying obesity-associated colon 
cancer, and that the DR may need to be excluded in such 
experiments. Distinguishing DIO and DR phenotypes 
can provide improved animal models for studying obesity-
associated colon cancer. Although a high-fat diet has 
been shown to increase body weight and increase polyp 
formation (22), the DIO mice could be a more accurate 
model. Our previous study showed that not every mouse 
responded identically to high-fat diet (13,14). It takes 
three stages to develop DIO with an increased intolerance 
to leptin (14). After being fed a high-fat diet, some mice 
became obese while others remained lean. DIO and 
DR mice have totally different profiles in many aspects 
including the expression levels of agouti-related peptide and 
neuropeptide Y in the brain (23). It has been shown that 
DIO mice have different gene expression profiles by using 
microarray and quantitative PCR such as genes involved in 
Wnt and BMP signalling pathways as well as the gene for 
mesoderm specific transcript (19,20). As all mice are inbred, 
these differences are considered to be caused by different 
epigenetic mechanisms. The differences in the activation of 
the signalling pathways caused by gene expression may also 
account for the increased polyps in DIO mice. Activation of 
survival signalling pathways can increase cell proliferation 
and decrease apoptosis to promote carcinogenesis (24-26). 
Taken together, we think that it could be necessary to use 
DIO not DR mice in order to investigate the link between 
obesity and colon cancer.
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Figure 1 Obesity induced by high-fat diet increased the formation of polyps induced by AOM. (A) The number of polyps counted; (B) 
polyps formed in the colon by AOM; (C) histological examination. DIO, diet-induced obese mice; DR, diet-resistant mice; LF, mice fed a 
low-fat diet; AOM, azoxymethane.
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